BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11493472)

  • 1. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion.
    Meech SJ; McGavran L; Odom LF; Liang X; Meltesen L; Gump J; Wei Q; Carlsen S; Hunger SP
    Blood; 2001 Aug; 98(4):1209-16. PubMed ID: 11493472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.
    Lamant L; Dastugue N; Pulford K; Delsol G; Mariamé B
    Blood; 1999 May; 93(9):3088-95. PubMed ID: 10216106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
    Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
    Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G
    Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.
    Sherman CG; Zielenska M; Lorenzana AN; Pulford KA; Mason DY; Hutchison RE; Thorner PS
    Pediatr Dev Pathol; 2001; 4(2):129-37. PubMed ID: 11178628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions.
    Elmberger PG; Lozano MD; Weisenburger DD; Sanger W; Chan WC
    Blood; 1995 Nov; 86(9):3517-21. PubMed ID: 7579458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The t(2;5) in human lymphomas.
    Kadin ME; Morris SW
    Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
    Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K; Lamant L; Morris SW; Butler LH; Wood KM; Stroud D; Delsol G; Mason DY
    Blood; 1997 Feb; 89(4):1394-404. PubMed ID: 9028963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
    Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features.
    Felgar RE; Salhany KE; Macon WR; Pietra GG; Kinney MC
    Hum Pathol; 1999 Feb; 30(2):228-36. PubMed ID: 10029454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK-positive anaplastic large cell lymphoma with TPM3-ALK translocation.
    Shin S; Kim J; Yoon SO; Kim YR; Lee KA
    Leuk Res; 2012 Jul; 36(7):e143-5. PubMed ID: 22591683
    [No Abstract]   [Full Text] [Related]  

  • 17. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
    Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
    Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like).
    Touriol C; Greenland C; Lamant L; Pulford K; Bernard F; Rousset T; Mason DY; Delsol G
    Blood; 2000 May; 95(10):3204-7. PubMed ID: 10807789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
    van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
    Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
    Ma Z; Cools J; Marynen P; Cui X; Siebert R; Gesk S; Schlegelberger B; Peeters B; De Wolf-Peeters C; Wlodarska I; Morris SW
    Blood; 2000 Mar; 95(6):2144-9. PubMed ID: 10706887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.